Related Experiment Video
Updated: Oct 31, 2025
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
30.8K
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes
Sanjay Khandelwal1, Ayiesha Barnes1, Lubica Rauova2
1Division of Hematology, Duke University Medical Center, Durham, NC.
Blood
|June 30, 2021
Summary
Heparin-induced thrombocytopenia (HIT) involves immune complexes activating complement. Complement activation enhances prothrombotic functions, suggesting new therapeutic targets beyond anticoagulation for HIT.
Area of Science:
- Immunology
- Hematology
- Complement System
Background:
- Heparin-induced thrombocytopenia (HIT) is a dangerous prothrombotic condition.
- Current therapies for HIT have limitations, necessitating new treatment strategies.
- Ultra-large immune complexes (ULICs) in HIT activate FcγRIIA, leading to procoagulant effects.
Purpose of the Study:
- To investigate the role of complement activation in HIT pathogenesis.
- To explore complement as a potential therapeutic target in HIT.
Main Methods:
- Studied interactions between HIT ULICs and C1q in buffer and plasma.
- Assessed complement activation via the classical pathway.
- Evaluated the impact of complement activation on monocyte tissue factor expression and FcγR binding.
Main Results:
- HIT ULICs activate complement (classical pathway) and co-deposit IgG and C3c on immune cells.
- Complement activation promotes FcγR-independent monocyte tissue factor expression.
- Complement activation enhances IgG binding to FcγRs and platelet adhesion.
Conclusions:
- Complement activation plays a significant role in HIT pathogenesis by regulating Fc-dependent effector functions.
- Targeting proximal complement pathway steps may offer non-anticoagulant therapeutic strategies for HIT.
- Findings provide insights into complement's role in immune complex-mediated thrombotic disorders.
Related Concept Videos
01:27Complement System
5.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
5.4K
01:26Antibody Actions
1.7K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
01:05Introduction to Hemostasis
10.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
10.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.3K
01:09Coagulation
8.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.6K